• Explore /
  • Poster
  • / AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma.

AMPLIFY-7P: Phase 1 and randomized phase 2 study of amphiphile immunotherapy ELI-002 7P as adjuvant treatment for subjects with G12D, G12R, G12V, G12C, G12A, G12S and G13D Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma.

Abstract Poster

Authors

null

Zev A. Wainberg

UCLA School of Medicine, Los Angeles, CA

Zev A. Wainberg , Vincent Chung , Craig E. Devoe , Thomas J. George , Esther Welkowsky , Thian Kheoh , Christopher M. Haqq , Shubham Pant , Eileen Mary O'Reilly

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05726864

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS720)

DOI

10.1200/JCO.2024.42.3_suppl.TPS720

Abstract #

TPS720

Poster Bd #

Q9

Abstract Disclosures

Similar Posters

First Author: Shubham Pant

First Author: Benjamin Adam Weinberg

First Author: Craig E. Devoe

First Author: Benjamin Adam Weinberg